Journal
BONE MARROW TRANSPLANTATION
Volume 42, Issue 4, Pages 227-240Publisher
SPRINGERNATURE
DOI: 10.1038/bmt.2008.162
Keywords
CMV; HHV-6; HHV-7; HHV-8; SCT; antiviral drugs
Categories
Ask authors/readers for more resources
These recommendations were prepared by the European Conference on Infections in Leukaemia following a predefined methodology. Literature searches were made to identify studies pertinent to management of CMV, HHV-6, -7 and -8 infections. For CMV, 76 studies were reviewed: 72 published and 4 presented as abstracts. Twenty-nine of these studies were prospective randomized trials. For the other herpesviruses, HHV-6, -7 and -8, no randomized controlled trial has been performed, although data from some studies with other primary endpoints have been used to assess the management of HHV-6 infection. Works presented only as abstracts were used to a very limited extent. The quality of evidence and level of recommendation were graded according to the Center for Disease Control (CDC) criteria.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available